Chronic pain and inflammation can stop your life in its tracks.
Daily pain can often mean a life full of misery. We’ve talked to many people who experience great pain whether they are doing simple tasks or simply nothing at all. This is a very difficult way to live.
Do you suffer from pain and inflammation? Has someone recommended you try CBD? Before you get started, you should know there are differences in the cannabinoids patients use to assist with pain. Many people are familiar with the difference between cannabidiol (CBD) and tetrahydrocannabinol (THC), but few have heard about cannabigerol (CBG) and its relationship to CBD.
CBD and CBG have many similarities. The greatest similarity would be in their potential medicinal benefits and therapeutic attributes. Both CBD and CBG are considered to be non-intoxicating cannabinoids. This means they do not produce a buzz or high like THC. CBD and CBG are said to have the potential of working as a neuroprotective, a pain reliever, and an antioxidant. When paired together, the two can be a potent anti-inflammatory combination.
An Intro to CBD
CBD, or cannabidiol, is a non-intoxicating compound found in cannabis. It was first discovered in the 1930s but wasn’t understood at the time. CBD is reported to have benefits ranging from helping reduce nausea and anxiety to being a pain reliever, an anti-inflammatory, a sleep aid, a neuroprotectant, and more.
An Intro to CBG
CBG is not quite as known as CBD, but it is beginning to step into the spotlight. Early research shows the promise of CBG having extraordinarily strong pain fighting properties, minus the intoxicating effects of THC. Research also indicates that CBG could offer other therapeutic benefits, such as serving as an antibacterial agent, an antidepressant, and providing anti-cancer bodily support (Dariš et al, 2019). CBG, however, is quite expensive and often referred to as the “Rolls Royce” of cannabinoids. This is because CBG can only be extracted from cannabis early on in cultivation because as the plants continue to grow, this cannabinoid converts to other cannabinoid lines such as CBD and THC.
CBD and CBG are remarkably similar. However, when it comes to how they work in your body, they are quite different. CBD is known to help individuals curb their appetite and is becoming a common part of healthy diet and exercise routines. CBG, in comparison, could help increase a person’s appetite as it has done in studies on animals, offering assistance to people struggling with loss of appetite or in recovery from cancer treatment side effects. CBG has shown evidence of being an anti-tumorigenic and helpful in attacking certain types of cancer. As you can see, combining the two together could create a powerhouse of cannabinoid benefits that may be transformative.
Perhaps They Are Just What the Doctor Didn’t Order
If you are living with pain and inflammation and looking for something that works to help relieve this discomfort, CBD and CBG may be just what the doctor didn’t order. Many physicians don’t understand the endocannabinoid system nor the subtle differences between various cannabinoids in aiding human health. Luckily, a prescription isn’t necessary for you to enjoy these cannabinoids and all they have to offer. So let us help you help yourself through CBD and CBG. We formulated our Relief Tincture to help people manage pain when CBD alone isn’t working. And we like to reward people for taking the time to learn so as a thank you for reading this article, we’ll give you 10% off when you use the code RELIEF10 at QultureClub.com.
Dariš, B., Tancer Verboten, M., Knez, Ž., & Ferk, P. (2019). Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosnian journal of basic medical sciences, 19(1), 14–23. https://doi.org/10.17305/bjbms.2018.3532
Navarro, G., Varani, K., Reyes-Resina, I., Sánchez de Medina, V., Rivas-Santisteban, R., Sánchez-Carnerero Callado, C., Vincenzi, F., Casano, S., Ferreiro-Vera, C., Canela, E. I., Borea, P. A., Nadal, X., & Franco, R. (2018). Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2Heteroreceptor Complexes. Frontiers in pharmacology, 9, 632. https://doi.org/10.3389/fphar.2018.00632